Hotspot Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2017-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.hotspotthera.com
A Study of HST-1011 Given as Monotherapy and in Combination With an Anti-PD1 Antibody
Phase 1
Active, not recruiting
- Conditions
- Solid Tumor, AdultRefractory CancerRelapsed Cancer
- Interventions
- First Posted Date
- 2022-12-22
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- HotSpot Therapeutics, Inc
- Target Recruit Count
- 77
- Registration Number
- NCT05662397
- Locations
- 🇺🇸
Florida Cancer Specialists, Sarasota, Florida, United States
🇺🇸Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States
🇺🇸Montefiore Einstein Comprehensive Cancer Center, Bronx, New York, United States
© Copyright 2025. All Rights Reserved by MedPath